# A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome

> **NCT02611609** · PHASE1,PHASE2 · COMPLETED · sponsor: **Healios K.K.** · enrollment: 36 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **BIOLOGICAL:** MultiStem
- **BIOLOGICAL:** MultiStem
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02611609
- **Lead sponsor:** Healios K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-09
- **Final completion:** 2019-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-11-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02611609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02611609, "A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02611609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*